Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Controlled trial of thalidomide for mucocutaneous lesions of Behcet's syndrome

May 28, 1998

FDA approves Apligraf Human Skin Equivalent for venous leg ulcers

May 27, 1998

Oral contraceptive approved for acne treatment in Canada

May 26, 1998

SKB patents another series of IL-8 antagonists

May 25, 1998

Solarase approved in Canada

May 25, 1998

TGF-beta3 proves ineffective for the treatment of oral mucositis

May 22, 1998

SmithKline Beecham and Leo will collaborate on dermatological R&D

May 21, 1998

IL-8 receptor antagonists described by SKB

May 19, 1998

FDA grants approval for pivotal clinical trial of Repel

May 12, 1998

Compounds for IL-8-mediated diseases in development at SmithKline Beecham

May 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...